Vor Bio (VOR) announced the appointment of Erez Kalir to its Board of Directors. The appointment represents a new seat on Vor Bio’s Board of Directors, which has been created in connection with the ...

Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity (PIPE) ...

CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez Kalir to its Board of ...

CAMBRIDGE, Mass. - Vor Biopharma (NASDAQ:VOR), a clinical-stage cell and genome engineering company with a market capitalization of $114 million, has announced the appointment of Erez Kalir to its ...

Erez Kalir does not have any significant net worth to report based on the numbers we have. This is based on reported shares in PAIN THERAPEUTICS INC.

In May, Erez Kalir, co-founder of multistrategy hedge fund firm Sabretooth Capital Management, was one of 17 speakers at the Ira Sohn Investment Conference. Held in New York, this annual event — where ...

Jan. 08, 2025 9:00 AM ETVor Biopharma Inc. (VOR) Mr. Kalir is a Rhodes Scholar and holds an MSc in cell biology from Magdalen College, Oxford, a JD from Yale Law School, and an A.B. with highest ...